botulinum
neurotoxin
bont
extrem
potent
toxin
contamin
food
public
health
concern
antibont
antibodi
describ
capabl
detect
bont
howev
still
exist
need
accur
sensit
detect
capabl
bont
herein
describ
character
panel
eight
monoclon
antibodi
mab
gener
nontox
receptorbind
domain
bont
h
c
develop
use
highthroughput
screen
approach
two
independ
hybridoma
fusion
two
group
four
igg
mab
develop
recombin
h
c
eight
singl
mab
bound
whole
bonta
protein
character
mab
slightli
prolong
time
death
vivo
mous
bioassay
map
pepscan
peptid
epitop
ntermin
subdomain
h
c
h
cn
compris
amino
acid
residu
wtlqdtqeikqrvvf
epitop
highli
immunoreact
human
furthermor
demonstr
bind
bonta
nanomolar
effici
togeth
result
indic
potenti
valu
diagnost
immunoreag
bonta
captur
assay
develop
bioforens
analysi
botulinum
neurotoxin
bont
exist
seven
distinct
serotyp
ag
caus
agent
botul
neuroparalyt
diseas
bont
among
toxic
substanc
known
estim
human
lethal
dose
ngkg
bodi
weight
natur
occur
botul
transpir
ingest
contamin
food
colon
gastrointestin
tract
bontproduc
clostridia
howev
rel
eas
product
lethal
bont
subtyp
result
inclus
categori
select
agent
toxin
list
furthermor
mass
vaccin
bont
unlik
due
rariti
natur
occur
diseas
limit
avail
crude
current
pentaval
vaccin
subsequ
inabl
use
bont
therapi
vaccin
neutral
antibodi
observ
protect
toxin
challeng
inde
polyclon
therapi
bont
includ
human
immunoglobulin
infant
botul
bont
serotyp
b
equin
immunoglobulin
adult
botul
bont
serotyp
b
e
addit
despeci
investig
heptaval
antitoxin
hbat
contain
antibodi
seven
known
bont
serotyp
recent
becom
avail
treat
adult
botul
potenti
sever
lethal
botul
poison
requir
patient
present
clinic
symptom
receiv
antitoxin
time
manner
receiv
definit
diagnosi
date
gold
standard
detect
bont
clinic
sampl
mous
toxic
assay
sensit
specif
assay
take
h
complet
requir
special
personnel
facil
reagent
resourc
due
advers
patient
reaction
occur
batch
variat
polyclon
immunoglobulin
product
desir
develop
rapid
method
diagnosi
permit
accur
sensit
bont
detect
serotyp
capabl
ensur
correct
cours
treatment
initi
soon
possibl
mani
effort
made
develop
altern
immunolog
base
assay
bont
detect
clinic
sampl
yet
assay
often
limit
avail
highqual
antibodi
product
monoclon
antibodi
mab
bont
excel
choic
sever
reason
first
mab
consist
lot
second
well
defin
theoret
unlimit
suppli
mammalian
cell
line
scale
readili
provid
mean
produc
clinic
grade
materi
third
murin
hybridoma
bioactiv
provid
good
lead
molecul
modifi
recombin
mean
improv
bioactiv
andor
less
immunogen
latter
exampl
simpl
chimer
strategi
investig
bont
structur
provid
invalu
inform
altern
strategi
antibodi
develop
bont
known
bont
synthes
inact
kda
pretoxin
compos
three
kda
function
domain
upon
secret
pretoxin
cleav
proteas
activ
disulfid
bondlink
dipeptid
consist
kda
light
chain
kda
heavi
chain
light
chain
contain
ntermin
catalyt
domain
heavi
chain
compris
kda
transloc
domain
h
n
kda
ctermin
receptorbind
domain
h
c
catalyt
domain
light
chain
zincendopeptidas
cleav
target
snare
solubl
nsf
attach
protein
receptor
complex
protein
neuromuscular
junction
prevent
neurotransmitt
releas
h
c
domain
contain
receptorbind
site
target
bont
cholinorogen
nerv
end
toxin
intern
via
receptormedi
endocytosi
h
n
transloc
domain
aid
intracellular
transloc
enzymat
activ
light
chain
host
cell
cytosol
h
c
bind
domain
correspond
residu
bonta
divid
two
kda
subdomain
ntermin
bbarrel
h
cn
subdomain
ctermin
btrefoil
fold
h
cc
subdomain
bont
propos
bind
host
cell
neuron
via
tworeceptor
mechan
wherea
bonta
bind
host
cell
gangliosid
follow
specif
bind
glycoprotein
receptor
within
synapt
vesicl
conserv
motif
hsxwyg
gangliosid
bind
locat
within
h
cc
bonta
bontb
specif
amino
acid
bonta
receptor
bind
yet
elucid
bontb
receptorbind
site
locat
within
h
cc
subdomain
like
region
provid
bonta
protein
receptor
site
well
immun
inert
h
c
domain
bont
provid
safe
ration
approach
mab
develop
toward
bont
disrupt
bont
bind
host
cell
receptor
negat
toxic
bioactiv
neutral
mab
h
c
receptorbind
domain
bont
wellestablish
limit
number
neutral
mab
specif
bonta
h
c
bind
domain
h
c
character
detail
three
neutral
antibodi
gener
phage
display
two
develop
murin
immun
librari
one
develop
human
librari
sever
studi
neutral
mab
specif
bonta
indic
oligoclon
mixtur
neutral
antibodi
provid
ration
design
potent
human
therapeut
given
seven
bont
exist
multipl
antigen
variant
one
expect
individu
mab
may
limit
vivo
protect
pool
welldefin
mab
requir
optim
protect
also
report
murin
mab
develop
use
classic
hybridoma
technolog
neutral
bonta
high
potenc
thu
potenti
develop
neutral
mab
murin
immun
sourc
gener
lead
molecul
bonta
serotyp
clearli
exist
herein
describ
develop
panel
mab
gener
use
recombin
nontox
h
c
bind
domain
bonta
character
epitop
mab
antibodi
bind
bonta
nanomolar
effici
may
serv
import
immunoreag
diagnost
assay
develop
gene
segment
bonta
strain
amino
acid
aa
access
bontb
strain
okra
aa
access
bont
strain
nctc
aa
access
use
clone
express
recombin
h
c
h
c
h
c
bind
domain
previous
describ
antibodi
reactiv
whole
bont
assess
use
avail
commerci
plate
metabiolog
madison
wi
elisa
protocol
whole
bont
toxin
correspond
bonta
strain
hall
bontb
strain
okra
b
bont
strain
alaska
e
b
og
approxim
mg
polypeptid
obtain
l
bacteri
cultur
puriti
two
polypeptid
confirm
sdspage
detect
western
immunoblot
use
rabbit
antisera
bont
h
c
immun
mice
gener
hybridoma
cell
line
describ
herein
conduct
describ
mab
first
clone
semisolid
agaros
clone
interest
underw
anoth
round
limit
dilut
subclon
ensur
monoclon
mab
isotyp
determin
use
commerci
dipstick
assay
roch
indianapoli
mab
manual
purifi
serumfre
cell
supernat
use
hitrap
protein
g
column
gehealthcar
bioscienc
accord
manufactur
recommend
mab
antigen
protein
concentr
conduct
use
bca
reagent
assay
pierc
reactiv
antibodi
via
elisa
conduct
follow
standard
oper
procedur
describ
previous
corbett
colleagu
lower
limit
detect
h
c
coat
concentr
rang
ng
fg
lower
limit
detect
defin
lowest
concentr
antigen
bind
observ
valu
least
four
time
greater
background
competit
elisa
ngml
incub
mgml
bsa
bonta
h
cc
h
cn
overnight
constant
endoverend
rotat
preincub
mab
dilut
across
plate
coat
ngwell
h
c
elisa
process
whole
toxin
elisa
conduct
use
plate
coat
bonta
bontb
bont
per
manufactur
recommend
metabiolog
sdspage
gel
western
immunoblot
perform
essenti
describ
previous
briefli
mg
h
c
h
c
h
c
h
cn
h
cc
irrelev
antigen
bovin
serum
albumin
electrophores
criterion
precast
polyacrylamid
gel
biorad
hercul
ca
follow
electrophoret
transfer
immobilonp
membran
millipor
bedford
immunoblot
block
use
bsa
wash
three
time
trisbuff
salin
tbst
bound
antibodi
detect
incub
hrpconjug
goat
antimous
igg
h
l
antibodi
southern
biotech
birmingham
al
dilut
tbst
develop
use
substrat
sigma
accord
manufactur
instruct
measur
affin
mab
bonta
h
c
perform
essenti
describ
previous
use
biacor
biacor
uppsala
sweden
biaevalu
softwar
use
measur
plot
k
k
valu
directli
use
calcul
bind
affin
k
peptid
cover
sequenc
bonta
h
c
synthes
overlap
five
residu
coupl
nylon
support
pin
format
pepscan
system
lelystad
netherland
manipul
pin
peptid
assembl
perform
place
tip
pin
well
elisa
plate
maxisorp
nalgenunc
rochest
ny
pin
block
bsapb
h
room
temperatur
follow
incub
mab
dilut
bsapb
hour
room
temperatur
wash
three
time
moder
shake
detect
mab
bind
pin
incub
secondari
antibodi
develop
western
immunoblot
pin
regener
accord
manufactur
instruct
reus
function
activ
mab
reactiv
whole
bont
assess
use
mous
protect
assay
mpa
previous
describ
mpa
conduct
follow
guidelin
institut
anim
use
care
committe
thoma
jefferson
univers
philadelphia
pa
mabmedi
protect
assess
vivo
mix
mg
mab
bonta
toxin
incub
ambient
temperatur
h
follow
inject
tail
vein
gm
swiss
webster
mice
n
follow
monitor
percent
surviv
day
spleen
mice
immun
recombin
bonta
h
c
fragment
use
two
hybridoma
fusion
procedur
two
fusion
result
develop
eight
antih
c
mab
produc
hybridoma
bonta
h
c
receptor
bind
domain
bont
fig
mab
except
isotyp
assess
bonta
reactiv
reveal
one
mab
strong
reactiv
whole
bonta
neurotoxin
therefor
chosen
character
fig
specif
reactiv
mab
assess
h
c
domain
bonta
bontb
bont
subdomain
h
cn
h
cc
fig
c
demonstr
previous
highthroughput
method
develop
studi
excel
serotyp
specif
h
c
domain
observ
crossreact
h
c
h
c
inde
mab
reactiv
h
cn
subdomain
reactiv
observ
h
cc
subdomain
via
elisa
denatur
western
immunoblot
analysi
fig
c
respect
lower
limit
detect
bonta
h
c
fragment
indirect
elisa
ng
assay
use
elisa
condit
employ
within
studi
fig
reactiv
mab
h
cn
demonstr
elisa
western
immunoblot
analysi
indic
antigen
site
resid
ntermin
h
cn
fragment
assess
specif
h
cn
subdomain
competit
elisa
conduct
inde
decreas
reactiv
h
c
observ
mab
preincub
h
cn
competit
observ
preincub
h
cc
irrelev
protein
bsa
fig
reactiv
denatur
h
c
h
cn
also
suggest
antibodi
bind
linear
epitop
defin
linear
epitop
recogn
pin
peptid
map
conduct
overlap
pin
peptid
cover
sequenc
bonta
h
c
receptorbind
domain
correspond
bonta
aa
residu
util
data
show
predominantli
bound
peptid
epitop
correspond
amino
acid
wtlqdtqeikqrvvf
fig
found
h
c
h
cn
recombin
protein
mab
bind
h
c
fragment
nanomolar
affin
measur
affin
mab
h
c
perform
via
surfac
plasmon
reson
analysi
k
k
rate
msec
sec
respect
result
k
nm
typic
affin
matur
mab
rais
bont
toxin
cell
depend
immun
respons
indic
h
c
immunogen
suitabl
surrog
immunogen
abl
portray
nativ
n
terminu
toxin
fig
analysi
h
c
epitop
bound
mab
pepscan
analysi
pin
peptid
epitop
map
mab
reactiv
neg
control
overlap
synthet
peptid
span
entir
amino
acid
sequenc
h
c
bind
specif
one
linear
epitop
wtlqdtqeikqrvvf
found
h
c
h
cn
b
sequenc
align
residu
bontb
bont
correspond
residu
bonta
demonstr
primari
amino
acid
sequenc
divers
region
ident
residu
conserv
residu
semiconserv
residu
residu
uniqu
bonta
repres
block
c
schemat
crystal
structur
bonta
reproduc
laci
associ
creat
raswin
softwar
enzymat
light
chain
repres
yellow
h
n
transloc
domain
repres
green
h
cn
blue
h
cc
magenta
epitop
residu
highlight
red
bonta
gangliosid
bind
residu
identifi
rummel
colleagu
depict
orang
space
residu
identifi
interact
neutral
antibodi
depict
pink
cyan
space
fill
serospecif
endpoint
elisa
titer
also
determin
whole
bont
crossreact
bontb
bont
observ
antibonta
titer
ngml
whole
bonta
toxin
elisa
fig
function
activ
mab
assess
use
mous
protect
assay
mpa
mice
challeng
bonta
preincub
mab
although
mab
abl
neutral
toxin
activ
death
observ
treat
mice
treatment
result
slightli
increas
time
death
p
fig
use
recombin
h
c
develop
mab
bonta
bind
linear
epitop
h
cn
subdomain
wtlqdtqeikqrvvf
nanomolar
affin
moreov
use
nontox
h
c
antigen
develop
mab
whole
bont
provid
safe
altern
develop
bont
detect
reagent
within
studi
one
mab
eight
highli
reactiv
whole
bonta
thu
select
studi
fact
abl
develop
antibodi
epitop
util
h
c
receptorbind
domain
select
crossreact
whole
bonta
surpris
epitop
surfac
expos
within
fulllength
bonta
fig
one
observ
slight
reactiv
pepscan
fig
second
peptid
correspond
amino
acid
tnasqagvekils
given
monoclon
antibodi
reactiv
like
due
crossreact
similar
amino
acid
residu
thu
artefact
vitro
pepscan
assay
sequenc
locat
within
h
c
subregion
bonta
specif
react
fig
interestingli
comparison
primari
amino
acid
sequenc
region
correspond
wtlqdtqeikqrvvf
epitop
bonta
bontb
bont
reveal
five
residu
ident
three
toxin
wherea
pair
comparison
bonta
bontb
bont
show
two
one
conserv
semiconserv
three
bont
respect
fig
inde
six
residu
uniqu
within
region
bonta
indic
bonta
residu
tqekr
critic
bind
strongli
suggest
region
intens
immun
environment
select
pressur
modest
neutral
bonta
mab
demonstr
interact
epitop
wtlqdtqeikqrvvf
slightli
decreas
function
activ
neurotoxin
partial
neutral
epitop
lie
within
h
cn
subdomain
h
c
region
greater
primari
sequenc
homolog
comparison
h
cc
subdomain
antigen
import
host
cell
gangliosid
bind
schemat
represent
bonta
one
observ
residu
import
host
cell
gangliosid
receptor
bind
locat
adjac
surfac
epitop
fig
orang
space
fill
interact
host
cell
gangliosid
first
low
affin
bind
interact
bring
toxin
close
proxim
host
cell
dual
receptor
model
bind
antibodi
bound
epitop
fig
red
space
fill
may
caus
steric
hindranc
partial
occlud
gangliosidebind
site
thu
provid
explan
delay
time
death
observ
within
studi
amino
acid
residu
interact
host
cell
protein
receptor
yet
clearli
elucid
garciarodriguez
colleagu
recent
cocrystal
neutral
antibodi
fragment
bont
thu
identifi
critic
contact
residu
neutral
amino
acid
residu
bonta
identifi
structur
bind
epitop
neutral
depict
pink
color
space
fill
residu
identifi
part
function
epitop
neutral
mab
depict
cyan
space
fill
fig
schemat
appear
epitop
bound
mab
interfer
key
neutral
residu
significantli
mab
specif
h
c
bound
linear
epitop
wtlqdtqeikqrvvf
within
h
cn
subdomain
nanomolar
affin
search
immun
epitop
databas
wwwimmuneepitop
org
reveal
minim
epitop
target
antibodi
respons
speci
part
longer
contigu
region
inde
epitop
studi
peptid
map
polyclon
immun
serum
rais
bonta
toxin
multipl
speci
use
radioimmunoassay
peptid
bonta
residu
found
immunodomin
human
chicken
recess
equin
outbr
mice
intriguingli
sera
cervic
dystonia
patient
treat
bonta
contain
neutral
antibodi
bound
epitop
residu
hybridoma
may
thu
rare
clone
polyclon
respons
inbr
mice
may
mirror
observ
attasi
dolimbek
studi
evalu
immunogen
discret
region
part
larger
polypeptid
immunogen
minim
target
remain
unknown
need
investig
given
empir
natur
protein
immunogen
nevertheless
data
reveal
first
minim
mab
epitop
wtlqdtqeikqrvvf
map
small
domain
importantli
find
mab
bind
specif
epitop
region
bonta
high
affin
epitop
target
highli
immunoreact
human
indic
potenti
valu
diagnost
immunoreag
bonta
captur
assay
develop
bioforens
analysi
